1. Home
  2. BHVN vs ERO Comparison

BHVN vs ERO Comparison

Compare BHVN & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • ERO
  • Stock Information
  • Founded
  • BHVN 2013
  • ERO 2016
  • Country
  • BHVN United States
  • ERO Canada
  • Employees
  • BHVN N/A
  • ERO N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • ERO
  • Sector
  • BHVN Health Care
  • ERO
  • Exchange
  • BHVN Nasdaq
  • ERO Nasdaq
  • Market Cap
  • BHVN 1.5B
  • ERO 1.5B
  • IPO Year
  • BHVN 2017
  • ERO N/A
  • Fundamental
  • Price
  • BHVN $13.92
  • ERO $16.82
  • Analyst Decision
  • BHVN Strong Buy
  • ERO Strong Buy
  • Analyst Count
  • BHVN 15
  • ERO 1
  • Target Price
  • BHVN $56.07
  • ERO $19.00
  • AVG Volume (30 Days)
  • BHVN 2.1M
  • ERO 647.8K
  • Earning Date
  • BHVN 11-11-2025
  • ERO 11-04-2025
  • Dividend Yield
  • BHVN N/A
  • ERO N/A
  • EPS Growth
  • BHVN N/A
  • ERO N/A
  • EPS
  • BHVN N/A
  • ERO 1.38
  • Revenue
  • BHVN N/A
  • ERO $535,974,000.00
  • Revenue This Year
  • BHVN N/A
  • ERO $64.82
  • Revenue Next Year
  • BHVN $2,002.87
  • ERO $30.05
  • P/E Ratio
  • BHVN N/A
  • ERO $12.19
  • Revenue Growth
  • BHVN N/A
  • ERO 20.59
  • 52 Week Low
  • BHVN $12.79
  • ERO $9.30
  • 52 Week High
  • BHVN $55.70
  • ERO $23.40
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 41.13
  • ERO 72.86
  • Support Level
  • BHVN $13.63
  • ERO $14.36
  • Resistance Level
  • BHVN $17.05
  • ERO $16.68
  • Average True Range (ATR)
  • BHVN 0.87
  • ERO 0.51
  • MACD
  • BHVN -0.23
  • ERO 0.28
  • Stochastic Oscillator
  • BHVN 8.01
  • ERO 87.40

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About ERO Ero Copper Corp.

Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.

Share on Social Networks: